Mazda, Fiat Chrysler Recall Vehicles Over Bosch Airbag Controls — Update
By Dean Seal
Mazda and Fiat Chrysler Automobiles both issued recalls over a software error in airbag-control modules manufactured by Robert Bosch GmbH's North American subsidiary.
The National Highway Traffic Safety Administration said in two reports that the error may cause the front airbags to deploy with excessive force during a crash.
Mazda's North American unit is recalling 77,670 of its MX-5 models produced from 2016 to 2023, while Fiat Chrysler is recalling 15,835 of its Fiat 124 Spider models produced from 2017 to 2020. Dealers can fix the issues by reprogramming the control module at no cost.
Both recall reports identify Robert Bosch LLC, the Farmington Hills, Mich.-based subsidiary of the privately held German company as the component manufacturer.
Mazda discovered the error during development of new airbag sensors and notified Stellantis Europe, the Italian subsidiary of Fiat Chrysler parent company Stellantis. Mazda isn't aware of any crashes or injuries reported in connection with the issue, NHTSA said.
In its report, Fiat Chrysler said the recall is related to a design issue where accelerometer-voltage specifications were set incorrectly and not a part defect.
"The decision to make any comments regarding recalls, as well as the responsibility for them, lies with the automaker concerned," Bosch said in a statement.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
September 27, 2024 17:12 ET (21:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks